Issue 1/2013
Content (32 Articles)
Postmenopausal breast cancer, androgens, and aromatase inhibitors
C. Campagnoli, P. Pasanisi, I. Castellano, C. Abbà, T. Brucato, F. Berrino
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis
Flora Zagouri , Theodoros N. Sergentanis, Rupert Bartsch, Anna S. Berghoff, Dimosthenis Chrysikos, Evandro de Azambuja, Meletios-Athanassios Dimopoulos, Matthias Preusser
Characteristics of basal cytokeratin expression in breast cancer
Alaa T. Alshareeda, Daniele Soria, Jonathan M. Garibaldi, Emad Rakha, Christopher Nolan, Ian O. Ellis, Andrew R. Green
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen
Diana E. Ramirez-Ardila, Jean C. Helmijr, Maxime P. Look, Irene Lurkin, Kirsten Ruigrok-Ritstier, Steven van Laere, Luc Dirix, Fred C. Sweep, Paul N. Span, Sabine C. Linn, John A. Foekens, Stefan Sleijfer, Els M. J. J. Berns, Maurice P. H. M. Jansen
DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients
Takahiko Kawate, Keiichi Iwaya, Ryoko Kikuchi, Hiroshi Kaise, Miki Oda, Eiichi Sato, Sadayuki Hiroi, Osamu Matsubara, Norio Kohno
Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts
Inna Y. Gong, Wendy A. Teft, Justin Ly, Yung-Hsiang Chen, Bruno Alicke, Richard B. Kim, Edna F. Choo
Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling
Susan Thrane, Anne E. Lykkesfeldt, Mathilde S. Larsen, Boe S. Sorensen, Christina W. Yde
Dynamics of lymphatic regeneration and flow patterns after lymph node dissection
Katrin S. Blum, Steven T. Proulx, Paola Luciani, Jean-Christophe Leroux, Michael Detmar
Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients
Vicente Peg, Martín Espinosa-Bravo, Begoña Vieites, Felip Vilardell, José R. Antúnez, Magdalena Sancho de Salas, Julio J. Delgado-Sánchez, Willy Pinto, Francisco Gozalbo, Anna Petit, Irene Sansano, María del Mar Téllez, Isabel T. Rubio
CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy
Wendy A. Teft, Inna Y. Gong, Brian Dingle, Kylea Potvin, Jawaid Younus, Theodore A. Vandenberg, Muriel Brackstone, Francisco E. Perera, Yun-Hee Choi, Guangyong Zou, Robin M. Legan, Rommel G. Tirona, Richard B. Kim
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer
Shanu Modi, Cristina Saura, Charles Henderson, Nancy U. Lin, Reshma Mahtani, Jill Goddard, Eduardo Rodenas, Clifford Hudis, Joyce O’Shaughnessy, Jose Baselga
The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial
Eric Hau, Lois Browne, Anne Capp, Geoff P. Delaney, Christopher Fox, John H. Kearsley, Ewan Millar, Elias H. Nasser, George Papadatos, Peter H. Graham
A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection
Jan J. Kootstra, Pieter U. Dijkstra, Hans Rietman, Jaap de Vries, Peter Baas, Jan H. B. Geertzen, Harald J. Hoekstra, Josette E. H. M. Hoekstra-Weebers
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer
Michelle A. Rudek, Roisin M. Connolly, Janelle M. Hoskins, Elizabeth Garrett-Mayer, Stacie C. Jeter, Deborah K. Armstrong, John H. Fetting, Vered Stearns, Laurie A. Wright, Ming Zhao, Stanley P. Watkins Jr., Howard L. McLeod, Nancy E. Davidson, Antonio C. Wolff
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer
Cynthia X. Ma, Vera J. Suman, Matthew Goetz, Paul Haluska, Timothy Moynihan, Rita Nanda, Olufunmilayo Olopade, Timothy Pluard, Zhanfang Guo, Helen X. Chen, Charles Erlichman, Matthew J. Ellis, Gini F. Fleming
Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program
Pål Møller, Astrid Stormorken, Christoffer Jonsrud, Marit Muri Holmen, Anne Irene Hagen, Neal Clark, Anita Vabø, Ping Sun, Steven A. Narod, Lovise Mæhle
Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
Raul Zamora-Ros, Pietro Ferrari, Carlos A. González, Anne Tjønneland, Anja Olsen, Lea Bredsdorff, Kim Overvad, Marina Touillaud, Florence Perquier, Guy Fagherazzi, Annekatrin Lukanova, Kaja Tikk, Krasimira Aleksandrova, Heiner Boeing, Antonia Trichopoulou, Dimitrios Trichopoulos, Vardis Dilis, Giovanna Masala, Sabina Sieri, Amalia Mattiello, Rosario Tumino, Fulvio Ricceri, H. Bas Bueno-de-Mesquita, Petra H. M. Peeters, Elisabete Weiderpass, Guri Skeie, Dagrun Engeset, Virginia Menéndez, Noémie Travier, Esther Molina-Montes, Pilar Amiano, Maria-Dolores Chirlaque, Aurelio Barricarte, Peter Wallström, Emily Sonestedt, Malin Sund, Rikard Landberg, Kay-Thee Khaw, Nicholas J. Wareham, Ruth C. Travis, Augustin Scalbert, Heather A. Ward, Elio Riboli, Isabelle Romieu
Poor compliance with breast cancer treatment guidelines in men undergoing breast-conserving surgery
Jordan M. Cloyd, Tina Hernandez-Boussard, Irene L. Wapnir
Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC)
Anna L. V. Johansson, Therese M.-L. Andersson, Chung-Cheng Hsieh, Karin Jirström, Paul Dickman, Sven Cnattingius, Mats Lambe
Prevalence of germline TP53 mutations in HER2+ breast cancer patients
Michelle G. Rath, Serena Masciari, Rebecca Gelman, Alexander Miron, Penelope Miron, Kathleen Foley, Andrea L. Richardson, Ian E. Krop, Sigitas J. Verselis, Deborah A. Dillon, Judy E. Garber
Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment
Nancy E. Avis, Beverly Levine, Michelle J. Naughton, L. Douglas Case, Elizabeth Naftalis, Kimberly J. Van Zee
Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient–provider relationship
Vanessa B. Sheppard, Claudine Isaacs, George Luta, Shawna C. Willey, Marc Boisvert, Felicity W. K. Harper, Karen Smith, Sara Horton, Minetta C. Liu, Yvonne Jennings, Fikru Hirpa, Felicia Snead, Jeanne S. Mandelblatt
The effect of atmospheric particulate matter on survival of breast cancer among US females
Hui Hu, Amy B. Dailey, Haidong Kan, Xiaohui Xu
Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study
Sarah Nechuta, Wei Lu, Ying Zheng, Hui Cai, Ping-Ping Bao, Kai Gu, Wei Zheng, Xiao Ou Shu
Reproductive factors and the risk of breast cancer in old age: a Norwegian cohort study
Julie Horn, Bjørn Olav Åsvold, Signe Opdahl, Steinar Tretli, Lars J. Vatten
Alcohol intake over the life course and breast cancer survival in Western New York exposures and breast cancer (WEB) study: quantity and intensity of intake
Anne M. Weaver, Susan E. McCann, Jing Nie, Stephen B. Edge, Thomas H. Nochajski, Marcia Russell, Maurizio Trevisan, Jo L. Freudenheim
Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women
Christy G. Woolcott, Kerry S. Courneya, Norman F. Boyd, Martin J. Yaffe, Anne McTiernan, Rollin Brant, Charlotte A. Jones, Frank Z. Stanczyk, Tim Terry, Linda S. Cook, Qinggang Wang, Christine M. Friedenreich
Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk
Ziang Yang, Juping Shen, Zhigang Cao, Biyun Wang
Radial scars and subsequent breast cancer risk: results from the Nurses’ Health Studies
Sarah A. Aroner, Laura C. Collins, James L. Connolly, Graham A. Colditz, Stuart J. Schnitt, Bernard A. Rosner, Susan E. Hankinson, Rulla M. Tamimi
Improper use of “radioguided occult lesion localization” (ROLL) technique leads to misleading conclusions
Giovanni Paganelli, Laura Gilardi, Umberto Veronesi
Letter to the Editor, Re: Night-shift work and risk of breast cancer (Kamdar et al., doi:10.1007/s10549-013-2433-1)
Richard Stevens, Johnni Hansen
Erratum to: Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis
Liling Zhu, Liang Jin, Shunrong Li, Kai Chen, Weijuan Jia, Quanyuan Shan, Stephen Walter, Erwei Song, Fengxi Su